DDi’s flagship product mEDC has been selected by one of the top 20 pharmaceutical company (HQ in Germany) as its preferred EDC tool along with integrated CDM services.
As part of the multi-year contract signed during Q2’ 2014 by the global head of regional clinical operations (sponsor), all its subsidiaries/ regional affiliates and CRO partners will be using mEDC and integrated CDM services for all its late phase studies in various countries.
During the selection process, the sponsor has evaluated many e-Clinical vendors and CRO service providers; and eventually shortlisted few of them for the next level of scrutiny. The sponsor has visited DDi offices globally and its datacenter in USA to audit all its processes, standards, IT infrastructure and e-clinical tools.
